Effects of chlorpheniramine on catheter-related bladder discomfort
Not Applicable
Completed
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0003236
- Lead Sponsor
- Konyang University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
1) 19 ~ 65year old
2) American Society of Anesthesiologist Patient Status I~III
3) Among patients scheduled for urologic surgery, those who require foley catheter insertion after induction of anesthesia
Exclusion Criteria
- Patients with prostatic hyperplasia
- Patients with irritable bladder symptoms
- Patients with bladder outlet obstruction
- Patients with glaucoma
- Psychiatric patients
- Patients with cognitive impairment
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of catheter-related bladder discomfort
- Secondary Outcome Measures
Name Time Method severity of catheter-related bladder discomfort
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chlorpheniramine's efficacy in alleviating catheter-related bladder discomfort?
How does chlorpheniramine compare to standard anticholinergics like oxybutynin for genitourinary catheter discomfort management?
Are there specific urothelial biomarkers that predict response to chlorpheniramine in catheterized patients?
What adverse events are associated with chlorpheniramine use in genitourinary interventions and how are they managed?
What combination therapies with chlorpheniramine show promise for treating catheter-induced bladder hypersensitivity?